Clinical Trials Browser

INDUSTRY × Interventional × Advanced Non-Small Cell Lung Cancer × Clear all

NCT05785767 2026-01-22

A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase 2/3 Active not recruiting

Advanced Non-Small Cell Lung Cancer

NCT07105176 2025-08-19

HS-IT101 Injection for Advanced NSCLC

Phase 1 Not yet recruiting

Advanced Non-Small Cell Lung Cancer

NCT06980272 2025-06-24

SSGJ-707 in Advanced Non-Small Cell Lung Cancer

Phase 3 Recruiting

Advanced Non-Small Cell Lung Cancer

NCT05504278 2025-01-27

Efficacy and Safety of IBI351 in Combination With Chemotherapy in Advanced Non-squamous Non-small Cell Lung Cancer Subjects With KRAS G12C Mutation

Phase 1 Recruiting

Advanced Non-Small Cell Lung Cancer

NCT04541706 2024-12-20

Lorlatinib in ALK Inhibitor Treated Unresectable Advanced/Recurrent ALK-Positive Non Small Cell Lung Cancer Patients in India

Phase 4 Completed

100 enrolled 10 charts

Advanced Non-Small Cell Lung Cancer

NCT00652561 2024-09-03

Phase 2 Study of S-1 as 2nd Line Therapy in Advanced Non-Small Cell Lung Cancer

Phase 2 Completed

Advanced Non-Small Cell Lung Cancer

NCT05978401 2023-08-07

Safety, Tolerability, and Efficacy of GLS-012 and GLS-010 in Patients With Advanced Non-Small Cell Lung Cancer

Phase 1/2 Not yet recruiting

Advanced Non-Small Cell Lung Cancer

NCT00064636 2005-06-24

Phase I Dose Escalation Study of VELCADE Plus Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors

Phase 1 Terminated

Other solid neoplasmThoracic

Advanced Non-Small Cell Lung Cancer